V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008336 | 220003339 | 1.66 | 102 | Palliative (P) | 2014-11-01 | 2014-11-01 | Carboplatin + Etoposide iv&po | N | null | 220034294 | CARBOPLATIN + ETOPOSIDE |
| 220008337 | 220003339 | null | 54.8 | Palliative (P) | 2015-02-01 | 2015-02-22 | ECX | N | N | 220034294 | ECX |
| 220008338 | 220003339 | null | 60 | Adjuvant (A) | null | 2014-07-09 | Cisplatin 100 + RT(H&N) 1 day | N | N | 220034294 | CISPLATIN + RT |
| 220008339 | 220003339 | 1.83 | 110 | Curative (C) | 2014-11-25 | 2014-11-26 | ADE 10+3+5 | 02 | N | 220034294 | ADE |
| 220008340 | 220003339 | 1.73 | 92.4 | Palliative (P) | null | 2016-01-31 | Carboplatin + Etoposide iv&po | N | N | 220034294 | CARBOPLATIN + ETOPOSIDE |
| 220008341 | 220003340 | null | 56 | Palliative (P) | 2016-09-29 | 2016-09-30 | EOX | 02 | N | 220034303 | EOX |
| 220008342 | 220011838 | 1.78 | 109 | Curative (C) | 2013-12-19 | 2013-12-24 | Cytarabine High Dose | N | N | 220034305 | CYTARABINE HIGH DOSE |
| 220008343 | 220011838 | 1.75 | null | Palliative (P) | 2014-11-01 | 2014-11-08 | EOX | N | N | 220034305 | EOX |
| 220008344 | 220011838 | 1.75 | 59.8 | Curative (C) | null | 2014-06-28 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | null | 220034305 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008345 | 220020474 | 1.63 | 60 | Palliative (P) | 2017-10-25 | 2017-11-01 | Carboplatin + Etoposide iv&po | 02 | N | 220034310 | CARBOPLATIN + ETOPOSIDE |
| 220008346 | 220003341 | 1.73 | 90.4 | null | 2015-09-30 | 2015-10-02 | Carboplatin + Etoposide IV 3 day | N | N | 220034312 | CARBOPLATIN + ETOPOSIDE |
| 220008347 | 220003342 | 1.7 | 55 | Curative (C) | 2016-03-08 | 2016-03-08 | AML Int Guide ADE 10+3+5 (1) | 02 | N | 220034320 | ADE |
| 220008348 | 220003342 | 1.56 | 75.9 | Curative (C) | 2013-01-16 | 2013-01-16 | AML Int Guide ADE 10+3+5 (1) | 2 | N | 220034320 | ADE |
| 220008349 | 220003343 | 1.72 | 71 | Curative (C) | 2015-12-13 | 2015-12-14 | Cytarabine High Dose | N | N | 220034322 | CYTARABINE HIGH DOSE |
| 220008350 | 220003344 | 1.54 | 71.4 | Disease modification (D) | 2016-08-20 | 2016-08-20 | Cisplatin + Radiotherapy | N | N | 220034323 | CISPLATIN + RT |
| 220008351 | 220003344 | 1.55 | 38.9 | null | 2014-01-05 | 2014-01-05 | CAPECITABINE + OXALIPLATIN | N | N | 220034323 | CAPECITABINE + OXALIPLATIN |
| 220008352 | 220003345 | 0.99 | null | Curative (C) | 2014-07-16 | 2014-07-16 | PEMBROLIZUMAB | N | null | 220034327 | RAVVA TRIAL |
| 220008353 | 220011841 | null | null | Palliative (P) | 2013-10-04 | 2013-10-29 | EOX | N | N | 220034334 | EOX |
| 220008354 | 220003346 | 1.6 | 68 | Not known (9) | null | 2014-08-11 | PEMBROLIZUMAB | N | N | 220034336 | RITUXIMAB |
| 220008355 | 220003347 | 1.73 | 80.6 | Curative (C) | 2015-12-13 | 2015-12-13 | Cytarabine High Dose | 2 | N | 220034337 | CYTARABINE HIGH DOSE |
| 220008356 | 220003347 | 1.73 | 109 | Not known (9) | 2017-03-02 | 2017-03-29 | PEMBROLIZUMAB | N | N | 220034337 | PEMBROLIZUMAB |
| 220008357 | 220003348 | 1.9 | 27.2 | Curative (C) | 2016-03-24 | 2016-04-07 | CARBOPLATIN | 02 | N | 220034339 | CARBOPLATIN |
| 220008358 | 220003349 | null | 47 | Palliative (P) | 2013-05-18 | 2013-06-01 | Oxaliplatin + Modified de Gramont | null | N | 220034340 | OXALIPLATIN + MDG |
| 220008359 | 220003349 | null | 70 | Palliative (P) | 2017-11-04 | 2017-11-09 | Oxaliplatin + Modified de Gramont | N | null | 220034340 | OXALIPLATIN + MDG |
| 220008360 | 220003349 | 1.85 | 56.6 | Curative (C) | null | 2017-10-18 | Cytarabine High Dose | N | N | 220034340 | CYTARABINE HIGH DOSE |
| 220008361 | 220003350 | 1.7 | 117.8 | Palliative (P) | 2015-03-01 | 2015-03-01 | Gemcitabine weekly | N | N | 220034344 | RAVVA TRIAL |
| 220008362 | 220003351 | 1.54 | 96.7 | Curative (C) | 2013-06-02 | 2013-06-02 | AML Int Guide ADE 10+3+5 (1) | 2 | N | 220034346 | ADE |
| 220008363 | 220003352 | 1.74 | 68 | Curative (C) | 2013-12-20 | 2013-12-20 | AML Int Guide ADE 10+3+5 (1) | N | Y | 220034352 | ADE |
| 220008364 | 220003352 | null | 76 | Curative (C) | null | 2014-09-21 | ADE 10+3+5 | N | N | 220034352 | ADE |
| 220008365 | 220003353 | null | 48.5 | Curative (C) | 2014-02-11 | 2014-02-12 | FLAG | N | null | 220034354 | FLAG |
| 220008366 | 220003353 | 1.87 | 67.3 | Curative (C) | 2014-07-19 | 2014-07-19 | ADE 10+3+5 | 1 | N | 220034354 | ADE |
| 220008367 | 220003354 | 1.52 | 79.2 | Palliative (P) | 2015-04-18 | 2015-05-02 | EOX | N | N | 220034356 | EOX |
| 220008368 | 220003354 | null | 58 | Palliative (P) | 2013-10-15 | 2013-10-15 | PEMBROLIZUMAB | N | N | 220034356 | RAVVA TRIAL |
| 220008369 | 220003355 | null | 74 | Palliative (P) | 2016-06-08 | 2016-06-11 | CARBOPLATIN | 02 | N | 220034364 | CARBOPLATIN |
| 220008370 | 220011847 | 1.55 | null | Not known (9) | 2016-10-01 | 2016-10-14 | Carboplatin AUC 6 - 10 | 02 | N | 220034365 | CARBOPLATIN |
| 220008371 | 220016377 | 1.6 | 82.7 | Disease modification (D) | 2016-07-20 | 2016-07-20 | GEMCITABINE | 02 | N | 220034369 | RITUXIMAB |
| 220008372 | 220016377 | 1.81 | 77 | Curative (C) | 2017-04-28 | 2017-04-30 | AML Int Guide ADE 10+3+5 (1) | 02 | Y | 220034369 | ADE |
| 220008373 | 220016377 | null | 77.2 | Palliative (P) | 2013-05-08 | 2013-05-12 | ECX | N | null | 220034369 | ECX |
| 220008374 | 220021312 | null | 84.5 | Palliative (P) | 2014-05-11 | 2014-05-11 | Capecitabine + Oxaliplatin 14day | null | null | 220034374 | CAPECITABINE + OXALIPLATIN |
| 220008375 | 220021312 | 1.7 | null | Not known (9) | 2015-09-05 | 2015-09-10 | CISPLATIN + RT | 1 | N | 220034374 | CISPLATIN + RT |
| 220008376 | 220021312 | 1.55 | 57.2 | Curative (C) | 2015-12-04 | 2015-12-04 | CISPLATIN + RT | N | N | 220034374 | CISPLATIN + RT |
| 220008377 | 220021312 | 1.63 | 60.9 | Curative (C) | 2014-02-20 | 2014-02-21 | FLAG | N | N | 220034374 | FLAG |
| 220008379 | 220003357 | 1.7 | 74 | Palliative (P) | 2014-03-04 | 2014-03-10 | ECX | 01 | N | 220034388 | ECX |
| 220008380 | 220003358 | 1.72 | 0 | Palliative (P) | 2016-06-10 | 2016-06-25 | ECX | N | N | 220034389 | ECX |
| 220008381 | 220003359 | 1.73 | 73.3 | Palliative (P) | 2014-03-07 | 2014-03-15 | Carboplatin + Etoposide iv&po | 02 | N | 220034390 | CARBOPLATIN + ETOPOSIDE |
| 220008382 | 220011848 | 1.8 | 114.7 | null | null | 2017-07-15 | FLAG | N | N | 220034391 | FLAG |
| 220008383 | 220011848 | null | null | Not known (9) | null | 2018-02-24 | PEMBROLIZUMAB | N | null | 220034391 | RITUXIMAB |
| 220008384 | 220011848 | 1.69 | null | Palliative (P) | 2015-07-25 | 2015-08-01 | Carboplatin + Etoposide iv&po | 2 | N | 220034391 | CARBOPLATIN + ETOPOSIDE |
| 220008385 | 220011848 | 1.6 | 67.7 | null | 2016-12-21 | 2016-12-21 | ECX | N | null | 220034391 | ECX |
| 220008390 | 220018980 | 1.76 | 78.8 | Palliative (P) | 2015-06-14 | 2015-07-02 | Carboplatin + Etoposide iv&po | N | N | 220034424 | CARBOPLATIN + ETOPOSIDE |